Radicava Infusion

Infusion Plus, Inc is now infusing Radicava!

This drug was first approved by the FDA in May, 2017. It is the first treatment option approved in more than twenty years for ALS otherwise known as Amyotrophic Lateral Sclerosis or Lou Gehrig’s Disease. In clinical trials, there was a decline in the loss of physical function in ALS patients being treated with Radicava.